Your browser doesn't support javascript.
Anti-SARS-CoV-2 antibodies seroprevalence among patients submitted to treatment for tuberculosis in Rio de Janeiro, Brazil: a cross-sectional study. (preprint)
medrxiv; 2021.
Preprint in English | medRxiv | ID: ppzbmed-10.1101.2021.11.17.21266274
ABSTRACT
Due to tuberculosis (TB) patients` pulmonary damages, some authors believe that a SARS-CoV-2 coinfection may result in unfavorable outcomes. A cross-sectional anti-SARS-CoV-2 antibodies seroprevalence study was conducted at a TB treatment tertiary referral unit in Rio de Janeiro, Brazil, to estimate the proportion (in %) of TB patients exposed to the new coronavirus and their main outcomes. Of 83 patients undergoing TB treatment, 26.5% have already been infected by the new coronavirus. Most patients were asymptomatic (69%) or had mild COVID-19 cases (31%). Only one patient required hospitalization. Among the symptoms and signs presented, the most frequently reported were fever, headache, and myalgia. People with less education and less purchasing power seemed to had been more exposed to SARS-CoV-2.
Subject(s)

Full text: Available Collection: Preprints Database: medRxiv Main subject: Tuberculosis / Coinfection / Myalgia / COVID-19 / Headache Language: English Year: 2021 Document Type: Preprint

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: Preprints Database: medRxiv Main subject: Tuberculosis / Coinfection / Myalgia / COVID-19 / Headache Language: English Year: 2021 Document Type: Preprint